SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Biotechnology Cancer Cures

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: smh who wrote (202)11/19/2000 11:13:02 AM
From: scaram(o)uche   of 226
 
"I have no doubt that 10 years from now, cancer vaccines will be a valid therapeutic approach for most solid tumors," says Donald Morton, director of the John Wayne Cancer Center.

Morton is a hero. However, in 1972, he was certain that BCG "vaccines" would work for melanoma.

Face to face with a variety of scientists in the past few years, none of the vaccine proponents have been able to dent my resolve as I've dented theirs.

<g>

NEXT BREATH.... I have no doubt whatsoever that normal tissue antigens, selectively displayed on cancers, can be effective vaccine targets. Many of the sector's efforts are goodies, IMO.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext